NCT06750601

Brief Summary

Within the Center of Rehabilitation multidisciplinary treatment is provided to people with various physical disabilities and/or chronic diseases. During and in the context of this treatment, a lot of data is routinely collected. Rehablines is initiated to re-use this routine clinical data in a database for future scientific research. Rehablines aims to: - Efficiently conduct high quality scientific research aimed at patient characteristics, underlying disease processes, and treatment effects; - Provide insight into (short and long-term) treatment effects and efficiency of these rehabilitation treatments; - Personalize treatment by comparing data from the individual patient with data from a large number of patients with similar characteristics from Rehablines.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20,000

participants targeted

Target at P75+ for all trials

Timeline
215mo left

Started Aug 2023

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress14%
Aug 2023Jan 2044

Study Start

First participant enrolled

August 1, 2023

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

December 9, 2024

Completed
18 days until next milestone

First Posted

Study publicly available on registry

December 27, 2024

Completed
19 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2044

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2044

Last Updated

December 27, 2024

Status Verified

December 1, 2024

Enrollment Period

20.4 years

First QC Date

December 9, 2024

Last Update Submit

December 24, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Clinical data

    Rehablines is a unique databank that purely re-uses clinical data for research. All data that is collected during the treatment of our patients can be re-used with patient consent.

    Timepoint 1: pre-treatment. Timepoint 2: throughout study completion (on average 12 weeks). Timepoint 3: up to 1 year follow up

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

In the UMCG-CvR rehabilitation care is provided to patients with a variety of physical disabilities and/or chronic diseases. Provided types of rehabilitation include for instance neurorehabilitation, orthopedic rehabilitation, oncology rehabilitation, pain rehabilitation, pediatric rehabilitation and rehabilitation in chronic illnesses, e.g. heart, lung, diabetes, thoracic and transplant rehabilitation. All patients who are starting their treatment in our facility are invited to participate in Rehablines.

You may qualify if:

  • all participants receiving care at the Center for Rehabilitation of the University Medical Center Groningen

You may not qualify if:

  • n.a.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Center for Rehabilitation of the University Medical Center Groningen

Groningen, 9700 RB, Netherlands

RECRUITING

Related Publications (1)

  • van Kammen K, Krops LA, Geertzen JHB, Dekker R. Rehablines: a Dutch further use databank to (re)use routine real world clinical data for scientific research in rehabilitation of people with physical disabilities and/or chronic diseases - a cohort profile. BMJ Open. 2025 Aug 8;15(8):e099089. doi: 10.1136/bmjopen-2025-099089.

Central Study Contacts

K van Kammen, PhD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 9, 2024

First Posted

December 27, 2024

Study Start

August 1, 2023

Primary Completion (Estimated)

January 1, 2044

Study Completion (Estimated)

January 1, 2044

Last Updated

December 27, 2024

Record last verified: 2024-12

Locations